National Oilwell Varco
NOV
$18.75
+0.37%
NOV Inc. is a leading global provider of equipment and components for the oil and gas industry, designing, manufacturing, and selling rig equipment, downhole tools, drill pipe, and well casing. The company operates as a major integrated supplier with a distinct competitive identity built on its extensive product portfolio and global scale, serving a diverse customer base from national oil companies to independent drillers. The current investor narrative centers on the company's ability to navigate energy sector volatility, as evidenced by a recent substantial 20% dividend increase signaling management's confidence in sustained cash flow generation, while debates persist around the sustainability of its recovery amid fluctuating quarterly profitability and revenue trends.…
NOV
National Oilwell Varco
$18.75
Related headlines
Investment Opinion: Should I buy NOV Today?
Rating: Hold. The core thesis is that NOV presents a classic value trap—attractive on static valuation and cash flow metrics but burdened by unstable fundamentals and negative near-term momentum, warranting a neutral stance until earnings visibility improves.
Supporting evidence includes a deeply discounted Price-to-Sales ratio of 0.665, a strong balance sheet with a 2.42 current ratio, and robust TTM free cash flow of $876 million enabling a 20% dividend hike. However, these positives are counterbalanced by a Q4 revenue decline of 1.34% YoY, a swing to a net loss, and a sharp -11% relative performance versus the market over the past month. Analyst forward EPS estimates of $1.84 imply a forward P/E of ~10.1x, which is not demanding if achieved.
The thesis would upgrade to a Buy if the PS ratio falls below 0.6 on sustained revenue growth or if quarterly operating margins stabilize above 7%. It would downgrade to a Sell if free cash flow turns negative or if the stock breaks below key technical support at $15. Relative to its history and the cyclical nature of its industry, the stock appears fairly valued to slightly undervalued, but not compelling enough to overcome the clear operational headwinds.
Sign up to view all
NOV 12-Month Price Forecast
NOV is a cyclical value stock caught between a discounted valuation and deteriorating fundamentals. The strong cash flow and balance sheet provide a floor, but the recent earnings volatility and revenue trend preclude a bullish stance. The neutral outlook is predicated on the base case of modest earnings delivery per analyst estimates ($1.84 EPS). The stance would upgrade to bullish on evidence of sequential revenue growth and margin expansion for two consecutive quarters. It would turn bearish if the stock breaks below $15 on high volume, signaling a failure of the value proposition.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on National Oilwell Varco's 12-month outlook, with a consensus price target around $24.38 and implied upside of +30.0% versus the current price.
Average Target
$24.38
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$15 - $24
Analyst target range
Analyst coverage for NOV appears limited, with only 3 analysts providing estimates for revenue and EPS, indicating this may be a lower-priority name for the sell-side. The consensus estimated EPS for the forward period is $1.84, with a range from $1.72 to $1.93, and estimated revenue averages $9.57 billion. Insufficient explicit target price and recommendation data (e.g., average price target, buy/hold/sell distribution) is available in the provided dataset to calculate a clear implied upside or downside, suggesting analyst coverage is sparse or not comprehensively captured. The limited coverage typically implies this is a mid-cap stock with constrained institutional interest, which can lead to higher volatility and less efficient price discovery, as the stock may be more influenced by commodity price movements and company-specific operational updates rather than sustained analyst scrutiny. The recent institutional rating actions show a mix of views, with Barclays upgrading from Underweight to Equal Weight in February 2026, while firms like Goldman Sachs maintain a Sell rating, reflecting high uncertainty and a lack of strong consensus on the forward path.
Bulls vs Bears: NOV Investment Factors
The investment debate for NOV centers on a clash between its attractive valuation and solid cash flow against volatile fundamentals and a deteriorating near-term momentum. The bull case is stronger on a long-term value basis, supported by a discounted PS ratio, strong balance sheet, and shareholder-friendly capital allocation. The bear case holds the stronger near-term evidence, highlighted by the recent quarterly loss, revenue decline, and sharp technical pullback. The single most important tension is whether the company's robust free cash flow generation ($876M TTM) can stabilize and translate into consistent earnings growth, or if the recent margin compression and revenue plateau signal a deeper cyclical downturn that the discounted valuation already anticipates.
Bullish
- Strong Free Cash Flow & Dividend Hike: NOV generated $876 million in TTM free cash flow, providing robust liquidity. Management's confidence is demonstrated by a 20% dividend increase, signaling a commitment to shareholder returns and belief in sustained cash generation despite sector volatility.
- Attractive Valuation on Sales Basis: The stock trades at a trailing PS ratio of 0.665, near the bottom of its multi-year historical range and below 1.0, which is often considered a discount for oilfield services firms. The forward PS of ~0.61 suggests the market is pricing in minimal growth, creating a potential value opportunity.
- Solid Balance Sheet & Liquidity: A strong current ratio of 2.42 and a manageable debt-to-equity ratio of 0.37 indicate financial resilience. This low leverage provides flexibility to navigate cyclical downturns and fund strategic initiatives or buybacks, as seen with the $85 million in Q4 repurchases.
- Positive Long-Term Technical Trend: Despite a recent pullback, the stock is up 35.5% over the past year, outperforming the S&P 500 by 10.5 percentage points. Trading at 87% of its 52-week range ($11.78-$21.55) suggests the primary uptrend from the low remains intact.
Bearish
- Volatile & Declining Profitability: The company swung to a Q4 net loss of $78 million (EPS -$0.21) from a profit of $108 million in Q2. Gross margin of 20.29% is down from a peak of 26.62% in Q2 2024, indicating significant earnings volatility and margin pressure.
- Revenue Plateau & Recent Decline: Q4 2025 revenue of $2.277 billion declined 1.34% year-over-year and is below the $2.308 billion from Q4 2024. This plateau challenges the growth narrative, especially as quarterly revenue has been volatile, moving from $2.103B in Q1 to $2.277B in Q4 2025.
- Sharp Recent Momentum Reversal: The stock is down 10.97% over the past month, underperforming the S&P 500 by 11.71 percentage points, and is down 0.11% over three months. This signals a significant near-term correction and potential exhaustion after the strong run to the 52-week high.
- Low Analyst Coverage & Mixed Sentiment: Only 3 analysts provide estimates, indicating limited institutional interest and potential for inefficient price discovery. Recent rating actions show high uncertainty, with Barclays upgrading to Equal Weight while Goldman Sachs maintains a Sell rating.
NOV Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 35.512% 1-year price change, but is currently experiencing a sharp pullback from recent highs. As of the latest close of $18.66, the price is trading at approximately 87% of its 52-week range ($11.78 to $21.55), positioning it near the upper end of the range but having retreated significantly from the high, suggesting recent momentum exhaustion and potential profit-taking after a strong run. Recent momentum has decisively turned negative, with the stock down 10.9733% over the past month and down 0.1071% over the past three months, a stark divergence from the positive longer-term trend that signals a significant near-term correction or consolidation phase. This negative short-term relative strength of -11.7133% versus the S&P 500's 0.74% gain over the same period underscores pronounced underperformance. Key technical support is at the 52-week low of $11.78, with immediate resistance at the recent 52-week high of $21.55; a breakdown below the recent low of $18.66 could signal a deeper correction towards the $15-16 consolidation zone from late 2025. The stock's beta of 0.905 indicates it is slightly less volatile than the broader market, which may provide some downside cushion during this corrective phase, though the recent max drawdown of -16.1% highlights the stock's susceptibility to sharp pullbacks within its cyclical trend.
Beta
0.91
0.91x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$12-$22
Price range past year
Annual Return
+41.8%
Cumulative gain past year
| Period | NOV Return | S&P 500 |
|---|---|---|
| 1m | -9.9% | -1.6% |
| 3m | -4.4% | +11.7% |
| 6m | +20.1% | +6.3% |
| 1y | +41.8% | +22.2% |
| ytd | +14.3% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NOV Fundamental Analysis
Revenue growth has been inconsistent, with the most recent quarterly revenue of $2.277 billion representing a slight year-over-year decline of 1.34%. The multi-quarter trend shows volatility: revenue grew from $2.103 billion in Q1 2025 to $2.277 billion in Q4 2025, but this Q4 figure is below the $2.308 billion reported in Q4 2024, indicating a plateau or slight contraction in the top line that challenges the growth narrative. Profitability is highly variable, with the company swinging to a net loss of $78 million (EPS of -$0.21) in Q4 2025 from a net income of $108 million (EPS of $0.29) in Q2 2025. The gross margin of 20.29% in Q4 is stable relative to recent quarters but down from the 26.62% peak in Q2 2024, indicating some margin compression, while the operating margin of 6.45% (from valuation data) reflects ongoing pressure on profitability. The balance sheet and cash flow position appear solid, with a strong current ratio of 2.42 and a manageable debt-to-equity ratio of 0.37. The company generated robust free cash flow of $876 million over the trailing twelve months, providing ample liquidity for the dividend increase and share repurchases, as evidenced by the $85 million in stock repurchased in Q4 2025. Return on equity is a modest 2.31%, indicating limited efficiency in generating profits from shareholder equity, which is consistent with the cyclical and competitive nature of the oilfield services industry.
Quarterly Revenue
$2.3B
2025-12
Revenue YoY Growth
-0.01%
YoY Comparison
Gross Margin
+0.20%
Latest Quarter
Free Cash Flow
$876000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NOV Overvalued?
Given the company reported negative net income in the most recent quarter, we lead with the Price-to-Sales (PS) ratio for valuation. The trailing PS ratio is 0.665, while the forward PS ratio can be inferred as approximately 0.61 based on a market cap of $5.81 billion and estimated revenue of $9.57 billion, suggesting the market expects modest revenue growth and potential margin improvement. Compared to typical oilfield services peers, a PS ratio below 1.0 often indicates a discount, which may reflect market skepticism about growth sustainability or cyclical headwinds, though specific industry average data is not provided for a quantified comparison. Historically, the stock's own PS ratio has fluctuated significantly, from a low near 0.67 in the current period to highs above 4.0 during the 2021-2022 period. The current PS of 0.665 is near the bottom of its multi-year historical range, which could signal a value opportunity if fundamentals stabilize, but also reflects the market's cautious stance given the recent quarterly loss and revenue volatility, pricing in a scenario of subdued growth and margin challenges.
PE
40.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -55x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks stem from NOV's volatile profitability and revenue concentration in the cyclical energy sector. The Q4 net loss of $78 million and a gross margin that has compressed from 26.6% to 20.3% over the past year highlight significant earnings risk. While free cash flow is strong, a Return on Equity of just 2.31% indicates poor capital efficiency. The company's performance remains tightly linked to oil & gas capital expenditure cycles, creating inherent revenue and margin volatility that challenges consistent earnings growth.
Market & Competitive Risks include valuation compression if the energy sector falls out of favor, though the current low PS ratio of 0.665 provides some buffer. The stock's beta of 0.905 suggests it is slightly less volatile than the market but has still experienced a max drawdown of -16.1%. Competitive pressures in the oilfield services industry could further pressure margins. The limited analyst coverage (only 3 analysts) exacerbates these risks, as it can lead to lower liquidity and sharper reactions to company-specific news, increasing volatility.
The Worst-Case Scenario involves a sustained downturn in oil & gas drilling activity, leading to consecutive quarterly losses, a breakdown of the recent technical support, and a re-rating to a deeper valuation discount. This could trigger a sell-off towards the 52-week low of $11.78. From the current price of $18.66, this represents a potential downside of approximately -37%. A more realistic severe bear case might see the stock retest the $15-16 consolidation zone, implying a loss of -15% to -20%, driven by earnings misses, dividend sustainability concerns, and broad sector outflows.
FAQ
The primary risks are: 1) Operational & Financial Risk: Extreme earnings volatility, as seen in the swing from a $108M profit in Q2 to a $78M loss in Q4, coupled with gross margin compression from 26.6% to 20.3%. 2) Sector Cyclicality Risk: Revenue is directly tied to oil & gas capex, making it highly sensitive to commodity price swings. 3) Market & Sentiment Risk: Limited analyst coverage (only 3 analysts) can lead to poor price discovery and high volatility, evidenced by a -16.1% max drawdown. 4) Technical Risk: The stock is in a sharp near-term downtrend, down 11% in the past month, which could indicate further selling pressure.
The 12-month outlook presents three scenarios. The Base Case (55% probability) sees the stock trading between $19 and $21, assuming it meets analyst EPS estimates of $1.84 and muddles through with volatile results. The Bull Case (25% probability) targets $22-$24 on a sector recovery and margin expansion. The Bear Case (20% probability) risks a drop to $12-$15 if oil prices fall and losses persist. The base case is most likely, hinging on the company's ability to stabilize profitability near current analyst projections. The recent price pullback has already priced in some of this uncertainty.
NOV appears fairly valued to slightly undervalued based on sales multiples, but the picture is mixed. The trailing Price-to-Sales ratio of 0.665 is near the bottom of its multi-year range and below 1.0, typically indicating a discount. However, the negative PEG ratio and high trailing P/E of 40.1 reflect recent earnings weakness. The market is pricing in low growth and margin challenges. Compared to the potential for recovery, the stock is not expensive, but the valuation is not compelling enough to ignore the fundamental headwinds without clearer signs of a turnaround.
NOV is a speculative buy for value investors comfortable with high cyclical risk. At a current PS ratio of 0.665, it trades at a discount to its historical range and many peers, with strong free cash flow supporting a recently increased 3.3% dividend yield. However, the recent Q4 net loss of $78 million and revenue decline pose significant near-term risks. It could be a good buy for a patient, diversified portfolio seeking energy sector exposure, but is not suitable for risk-averse or short-term investors given its volatility and uncertain earnings path.
NOV is more suitable for a long-term (3+ year) investment horizon due to its cyclical nature. Short-term trading is challenged by high earnings volatility, limited analyst coverage leading to unpredictable reactions, and a beta of 0.905 that doesn't fully insulate it from market swings. The dividend, recently increased by 20%, adds an income component for long-term holders. Investors should be prepared to hold through multiple energy cycle phases to realize the potential value embedded in its discounted sales multiple and strong cash flow generation.